JP2012062328A5 - - Google Patents

Download PDF

Info

Publication number
JP2012062328A5
JP2012062328A5 JP2011283904A JP2011283904A JP2012062328A5 JP 2012062328 A5 JP2012062328 A5 JP 2012062328A5 JP 2011283904 A JP2011283904 A JP 2011283904A JP 2011283904 A JP2011283904 A JP 2011283904A JP 2012062328 A5 JP2012062328 A5 JP 2012062328A5
Authority
JP
Japan
Prior art keywords
delivery vehicle
topical delivery
biophysical environment
agent
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011283904A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012062328A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012062328A publication Critical patent/JP2012062328A/ja
Publication of JP2012062328A5 publication Critical patent/JP2012062328A5/ja
Pending legal-status Critical Current

Links

JP2011283904A 2004-04-19 2011-12-26 不利な生物物理学的環境によりもたらされる有益な物質の経皮送達 Pending JP2012062328A (ja)

Applications Claiming Priority (50)

Application Number Priority Date Filing Date Title
US56356504P 2004-04-19 2004-04-19
US56356704P 2004-04-19 2004-04-19
US56357304P 2004-04-19 2004-04-19
US56355104P 2004-04-19 2004-04-19
US56357604P 2004-04-19 2004-04-19
US56356204P 2004-04-19 2004-04-19
US56355904P 2004-04-19 2004-04-19
US56356004P 2004-04-19 2004-04-19
US56356304P 2004-04-19 2004-04-19
US56357004P 2004-04-19 2004-04-19
US56355504P 2004-04-19 2004-04-19
US56355704P 2004-04-19 2004-04-19
US56355304P 2004-04-19 2004-04-19
US56356104P 2004-04-19 2004-04-19
US56355204P 2004-04-19 2004-04-19
US56355404P 2004-04-19 2004-04-19
US56355804P 2004-04-19 2004-04-19
US56356904P 2004-04-19 2004-04-19
US56357204P 2004-04-19 2004-04-19
US56357104P 2004-04-19 2004-04-19
US56357504P 2004-04-19 2004-04-19
US56357404P 2004-04-19 2004-04-19
US56356404P 2004-04-19 2004-04-19
US56356604P 2004-04-19 2004-04-19
US56355604P 2004-04-19 2004-04-19
US60/563,553 2004-04-19
US60/563,559 2004-04-19
US60/563,569 2004-04-19
US60/563,562 2004-04-19
US60/563,570 2004-04-19
US60/563,555 2004-04-19
US60/563,557 2004-04-19
US60/563,576 2004-04-19
US60/563,575 2004-04-19
US60/563,564 2004-04-19
US60/563,563 2004-04-19
US60/563,566 2004-04-19
US60/563,567 2004-04-19
US60/563,558 2004-04-19
US60/563,556 2004-04-19
US60/563,565 2004-04-19
US60/563,551 2004-04-19
US60/563,552 2004-04-19
US60/563,572 2004-04-19
US60/563,573 2004-04-19
US60/563,574 2004-04-19
US60/563,571 2004-04-19
US60/563,554 2004-04-19
US60/563,560 2004-04-19
US60/563,561 2004-04-19

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007509552A Division JP5630942B2 (ja) 2004-04-19 2005-04-19 不利な生物物理学的環境によりもたらされる有益な物質の経皮送達

Publications (2)

Publication Number Publication Date
JP2012062328A JP2012062328A (ja) 2012-03-29
JP2012062328A5 true JP2012062328A5 (enExample) 2012-09-27

Family

ID=35196712

Family Applications (8)

Application Number Title Priority Date Filing Date
JP2007509552A Expired - Lifetime JP5630942B2 (ja) 2004-04-19 2005-04-19 不利な生物物理学的環境によりもたらされる有益な物質の経皮送達
JP2007509553A Withdrawn JP2007532697A (ja) 2004-04-19 2005-04-19 局所的血流増大の有益な効果
JP2011093358A Pending JP2011140525A (ja) 2004-04-19 2011-04-19 局所的血流増大の有益な効果
JP2011273409A Withdrawn JP2012056964A (ja) 2004-04-19 2011-12-14 局所的血流増大の有益な効果
JP2011283904A Pending JP2012062328A (ja) 2004-04-19 2011-12-26 不利な生物物理学的環境によりもたらされる有益な物質の経皮送達
JP2012172904A Withdrawn JP2012211201A (ja) 2004-04-19 2012-08-03 不利な生物物理学的環境によりもたらされる有益な物質の経皮送達
JP2015088079A Withdrawn JP2015164932A (ja) 2004-04-19 2015-04-23 不利な生物物理学的環境によりもたらされる有益な物質の経皮送達
JP2015088080A Pending JP2015131861A (ja) 2004-04-19 2015-04-23 不利な生物物理学的環境によりもたらされる有益な物質の経皮送達

Family Applications Before (4)

Application Number Title Priority Date Filing Date
JP2007509552A Expired - Lifetime JP5630942B2 (ja) 2004-04-19 2005-04-19 不利な生物物理学的環境によりもたらされる有益な物質の経皮送達
JP2007509553A Withdrawn JP2007532697A (ja) 2004-04-19 2005-04-19 局所的血流増大の有益な効果
JP2011093358A Pending JP2011140525A (ja) 2004-04-19 2011-04-19 局所的血流増大の有益な効果
JP2011273409A Withdrawn JP2012056964A (ja) 2004-04-19 2011-12-14 局所的血流増大の有益な効果

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2012172904A Withdrawn JP2012211201A (ja) 2004-04-19 2012-08-03 不利な生物物理学的環境によりもたらされる有益な物質の経皮送達
JP2015088079A Withdrawn JP2015164932A (ja) 2004-04-19 2015-04-23 不利な生物物理学的環境によりもたらされる有益な物質の経皮送達
JP2015088080A Pending JP2015131861A (ja) 2004-04-19 2015-04-23 不利な生物物理学的環境によりもたらされる有益な物質の経皮送達

Country Status (7)

Country Link
US (10) US9050365B2 (enExample)
EP (2) EP1737441A4 (enExample)
JP (8) JP5630942B2 (enExample)
AU (2) AU2005235309B2 (enExample)
CA (2) CA2563670C (enExample)
ES (1) ES2429443T3 (enExample)
WO (2) WO2005102307A2 (enExample)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629384B2 (en) * 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US7914814B2 (en) 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20060140984A1 (en) 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
WO2005081964A2 (en) * 2004-02-23 2005-09-09 Strategic Science & Technologies, Llc Topical delivery of a nitric oxide donor to improve body and skin appearance
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
CA2563670C (en) * 2004-04-19 2014-09-16 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
US20110028548A1 (en) * 2004-04-19 2011-02-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
HUP0401422A2 (en) * 2004-07-15 2006-04-28 G Laszlo Meszaros Use of l-arginine as vasoaktive ingredient absorbing through skin for external application
CA2606565C (en) 2005-05-27 2016-05-10 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
AU2009205314A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US8367122B2 (en) 2008-06-11 2013-02-05 Biochemics, Inc. Control of blood vessel physiology to treat skin disorders
CA2749941C (en) 2008-09-10 2018-04-24 Biochemics, Inc. Ibuprofen for topical administration
WO2010034019A1 (en) 2008-09-22 2010-03-25 Biochemics, Inc. Transdermal drug delivery using an osmolyte and vasoactive agent
ES2400210T3 (es) 2008-10-02 2013-04-08 Mylan Inc. Método para preparar un laminado de adhesivo multicapa
BRPI0921959A2 (pt) 2008-12-04 2017-05-30 Biochemics Inc métodos e composições para remoção de tatuagem
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
EP2445493A1 (en) 2009-06-24 2012-05-02 Strategic Science & Technologies, LLC Topical composition containing naproxen
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
CN104069060A (zh) * 2009-06-24 2014-10-01 战略科学技术有限公司 含有布洛芬的表面组合物
AU2015203547B2 (en) * 2009-06-24 2017-05-18 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
EP2445492B1 (en) 2009-06-24 2016-09-28 Strategic Science & Technologies, LLC Topical composition containing ibuprofen
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CN102695528B (zh) 2009-08-21 2016-07-13 诺万公司 创伤敷料、其使用方法及其形成方法
CA3062005C (en) 2009-08-21 2022-02-15 Novan, Inc. Topical gels comprising nitric oxide-releasing polysiloxane macromolecules and uses thereof
EP2482788B1 (en) 2009-10-02 2022-12-14 Journey Medical Corporation Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US20130109674A1 (en) * 2009-12-18 2013-05-02 Achelios Therapeutics Llc Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
CN114668851B (zh) 2010-12-29 2024-11-01 战略科学与技术有限责任公司 勃起功能障碍和其它适应症的治疗
JP2014501285A (ja) * 2010-12-29 2014-01-20 ストラテジック サイエンス アンド テクノロジーズ, エルエルシー 片頭痛および他の適応症の処置のための方法およびシステム
WO2012092523A1 (en) * 2010-12-29 2012-07-05 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
CN103429246A (zh) * 2010-12-29 2013-12-04 战略科学与技术有限责任公司 真菌感染和其它适应症的治疗的透皮递送
JP2014501284A (ja) * 2010-12-29 2014-01-20 ストラテジック サイエンス アンド テクノロジーズ, エルエルシー Cox−2阻害剤および関連化合物、ならびにそれらを送達するためのシステムおよび方法
EP2681286B1 (en) 2011-02-28 2018-08-15 Novan, Inc. Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same
JP2016513686A (ja) 2013-03-15 2016-05-16 ストラテジック サイエンス アンド テクノロジーズ, エルエルシー フルチカゾンの経皮製剤
JP2016513690A (ja) 2013-03-15 2016-05-16 ストラテジック サイエンス アンド テクノロジーズ, エルエルシー シルデナフィルおよび他のホスホジエステラーゼ5阻害剤の経皮送達
WO2015021382A2 (en) 2013-08-08 2015-02-12 Novan, Inc. Topical compositions and methods of using the same
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
EP3226972A4 (en) 2014-12-01 2018-08-08 Achelios Therapeutics, Inc. Methods and compositions for treating migraine and conditions associated with pain
WO2016112201A1 (en) 2015-01-07 2016-07-14 Strategic Science & Technologies, Llc Techniques and systems for transdermal delivery involving treatment of psoriasis, skin cancer, and other indications
AR102172A1 (es) * 2015-10-05 2017-02-08 Química Luar S R L Una composición farmacéutica bactericida y virucida
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
RU2651767C1 (ru) * 2017-07-11 2018-04-23 федеральное государственное бюджетное образовательное учреждение высшего образования "Ростовский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РостГМУ Минздрава России) Способ лечения невралгии тройничного нерва

Family Cites Families (193)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5799M (enExample) 1966-03-22 1968-03-25
FR5940M (enExample) 1966-10-18 1968-04-08
FR1553063A (enExample) 1967-11-28 1969-01-10
US3960782A (en) 1974-09-27 1976-06-01 The Procter & Gamble Company Shampoo compositions which impart high luster and manageability to hair
US4185100A (en) 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
JPS5753404A (en) 1980-09-17 1982-03-30 Kao Corp External preparation for skin obtained by blending plant extract
GB2094142B (en) * 1981-03-06 1984-09-26 Lab For Applied Biology Ltd Injectable solution containing theophylline and a basic amino acid
GB2126868B (en) 1982-09-20 1986-03-19 Ralston Purina Co Method of improving the shelf life of processed meat products
DE3327840C1 (de) 1983-08-02 1984-09-20 Blendax Werke Schneider Co Hautpflegemittel
FR2557452B1 (fr) 1983-12-28 1986-08-14 Roussel Uclaf Nouvelles compositions pour les soins de la peau renfermant de l'huile d'onagre et des traits tissulaires de rate
US4681897A (en) 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
JPS60252412A (ja) 1984-05-29 1985-12-13 Nichiban Co Ltd 貼布治療製剤
US4722837A (en) 1984-05-29 1988-02-02 Derma-Cure, Inc. Medicated shampoo composition
US4692462A (en) 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US4732892A (en) 1985-07-12 1988-03-22 American Home Products Corporation L-α-amino acids as transdermal penetration enhancers
ES2038122T3 (es) 1985-11-18 1993-07-16 Beecham Group Plc Un procedimiento para la preparacion de una composicion veterinaria2.
GB8606368D0 (en) 1986-03-14 1986-04-23 Unilever Plc Skin treatment composition
FR2602678B1 (fr) 1986-08-13 1992-06-05 Drouault Guy Composition pharmaceutique aqueuse a base de sels de magnesium, sodium et potassium pour la regulation des circulations locales
US4940456A (en) 1987-02-10 1990-07-10 Dan Sibalis Electrolytic transdermal delivery of proteins
US4885157A (en) 1987-02-13 1989-12-05 Fiaschetti Mary G Dermal cosmetic composition and applications therefor
DE3715576A1 (de) 1987-05-09 1988-11-24 Wella Ag Neue makromolekulare, oberflaechenaktive, quaternaere n-substituierte chitosanderivate sowie kosmetisches mittel auf der basis dieser neuen chitosanderivate
KR900004875Y1 (ko) 1987-10-02 1990-05-31 삼성전자 주식회사 Pip의 수평 윈도우 신호발생 회로
JPH045231Y2 (enExample) 1987-12-16 1992-02-14
US5925372A (en) 1987-12-16 1999-07-20 Novartis Corporation Mixed solvent mutually enhanced transdermal therapeutic system
US4871718A (en) 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
GB2217595B (en) * 1988-04-21 1991-11-20 American Cyanamid Co Antiinflammatory gel
DE3827362A1 (de) * 1988-08-12 1990-02-15 Basf Ag Pulvrige, hydrophile theophyllinformulierung und verfahren zur ihrer herstellung
FI902673A7 (fi) 1988-09-30 1990-05-29 Kazuo Watanabe Anti-inflammatoorisia ja analgeettisia yhdisteitä, niitä sisältäviä se oksia ja menetelmiä niiden valmistamiseksi sekä niiden käyttö
US4945901A (en) 1989-03-22 1990-08-07 Burcke Jr Harry J Hand therapy apparatus and method therefor
US5158761A (en) 1989-04-05 1992-10-27 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
US5476852A (en) 1989-05-03 1995-12-19 Janssen Pharmaceutica N.V. Method of topically treating acne vulgaris, hyperkeratotic dermatoses, and photo-aging of the skin
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
JP2761939B2 (ja) 1989-09-04 1998-06-04 株式会社コーセー 水中油型乳化化粧料
PT95564B (pt) 1989-10-17 1997-11-28 Merck & Co Inc Processo para a preparacao de (+)-ibuprofen-d-aminoacido uteis como analgesicos intensificados de ataque acelerado
US5576351A (en) 1989-12-29 1996-11-19 Mcgaw, Inc. Use of arginine as an immunostimulator
EP0441119A3 (en) 1990-01-09 1992-10-14 Richard D. Levere The use of l-arginine in the treatment of hypertension and other vascular disorders
US5332758A (en) 1990-07-13 1994-07-26 Kanebo, Ltd. Collagen metabolism ameliorant and its use
US5824658A (en) 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
JPH06501947A (ja) 1990-11-14 1994-03-03 ジ・アップジョン・カンパニー 5−フルオロ−2,4,6−ピリミジントリアミン化合物
DE4100975A1 (de) 1991-01-15 1992-07-16 Weuffen Wolfgang Kosmetische oder pharmazeutische zubereitungen zur verbesserung der haarqualitaet und foerderung des haarwachstums
US5210099A (en) * 1991-02-11 1993-05-11 American Home Products Corporation Analgesic compositions
EP0531495B1 (en) 1991-03-01 1997-08-20 Atherton Investments, Ltd. Therapeutic and cosmetic compositions for treatment of skin
CA2105313A1 (en) 1991-03-01 1992-09-02 Rafael Abad Therapeutic and cosmetic compositions for treatment of skin
US5498420A (en) 1991-04-12 1996-03-12 Merz & Co. Gmbh & Co. Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions
ATE121390T1 (de) 1991-05-27 1995-05-15 Fujisawa Pharmaceutical Co N-pentadecylnicotinat-n-oxid sowie dieses enthaltendes haarregenerierendes mittel.
JP2636118B2 (ja) 1991-09-10 1997-07-30 三省製薬株式会社 育毛剤
US5254331A (en) 1991-09-12 1993-10-19 Chanel, Inc. Skin cream composition
US5215759A (en) 1991-10-01 1993-06-01 Chanel, Inc. Cosmetic composition
US5217652A (en) 1991-10-04 1993-06-08 The Gillette Company Conditioning shampoo
ATE169826T1 (de) 1992-01-21 1998-09-15 Macrochem Corp Iontophoretische verbesserte verabreichung von medikamenten
JP3302995B2 (ja) * 1992-04-01 2002-07-15 株式会社ダイゾー エアゾール組成物
US5632981A (en) 1992-08-24 1997-05-27 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5405919A (en) 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US5691423A (en) 1992-08-24 1997-11-25 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-bound nitric oxide-nucleophile adducts
US5464954A (en) 1992-08-31 1995-11-07 Idec Izumi Corporation Safety switch assembly
DK169121B1 (da) * 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
GB9222772D0 (en) 1992-10-30 1992-12-09 Unilever Plc Cosmetic composition
US5573776A (en) 1992-12-02 1996-11-12 Alza Corporation Oral osmotic device with hydrogel driving member
JP3191833B2 (ja) 1993-02-24 2001-07-23 三菱東京製薬株式会社 育毛剤
JPH06287135A (ja) 1993-04-01 1994-10-11 Lion Corp 皮膚外用剤組成物
US5439938A (en) 1993-04-07 1995-08-08 The Johns Hopkins University Treatments for male sexual dysfunction
GB9311920D0 (en) 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US5852058A (en) 1993-06-11 1998-12-22 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
US5891459A (en) 1993-06-11 1999-04-06 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
US5428070A (en) 1993-06-11 1995-06-27 The Board Of Trustees Of The Leland Stanford Junior University Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity
DE4338793A1 (de) 1993-11-12 1995-05-18 Froelich Juergen C L-Arginin und Analoge als Thrombozytenaggregationshemmer
DE4341000A1 (de) 1993-12-02 1995-06-08 Beiersdorf Ag Verwendung von L-Arginin, L-Ornithin oder L-Citrullin und topischen Zubereitungen mit diesen Stoffen
US5714472A (en) 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
GB9409281D0 (en) 1994-05-10 1994-06-29 Svedman Paul Transdermal device
JPH07316075A (ja) 1994-05-26 1995-12-05 Pola Chem Ind Inc 皮膚外用剤
US6190704B1 (en) 1994-09-23 2001-02-20 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Regulation of wound healing by nitric oxide
US5543430A (en) 1994-10-05 1996-08-06 Kaesemeyer; W. H. Method and formulation of stimulating nitric oxide synthesis
US5505958A (en) * 1994-10-31 1996-04-09 Algos Pharmaceutical Corporation Transdermal drug delivery device and method for its manufacture
ATE205723T1 (de) 1994-11-04 2001-10-15 Polymun Scient Immunbio Forsch Applikation von sod in liposomen
US5594032A (en) 1994-11-10 1997-01-14 Gonzalez-Cadavid; Nestor F. Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA
US5648101A (en) 1994-11-14 1997-07-15 Tawashi; Rashad Drug delivery of nitric oxide
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
US5853768A (en) 1995-03-01 1998-12-29 Altadonna; James Topical preparation and method for pain relief
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5595753A (en) 1995-04-14 1997-01-21 President And Fellows Of Harvard College Topical formulations and methods for treating hemorrhoidal pain and sphincter and smooth muscle spasm in the gastrointestinal tract
US5643586A (en) 1995-04-27 1997-07-01 Perricone; Nicholas V. Topical compositions and methods for treatment of skin damage and aging using catecholamines and related compounds
US5698738A (en) 1995-05-15 1997-12-16 Board Of Regents, The University Of Texas System N-nitroso-N-substituted hydroxylamines as nitric oxide donors
US5762963A (en) * 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
US5645859A (en) 1995-10-02 1997-07-08 Isp Investments Inc. Process for producing an alpha or beta-hydroxy acid-vinylpyrrolidone polymer, copolymer or graft polymer complex in the form of free-flowing powders having a high acid loading
US5605685A (en) 1995-09-13 1997-02-25 Isp Investments Inc. Non-irritating skin and hair rejuvenating compostion having a pH between 1 and 6.5
US5734080A (en) 1995-09-22 1998-03-31 Anihealth Corporation Reaction product of arginine and p-aminobenzoic acid, cosmetic, and human and animal health compositions thereof
US6036977A (en) * 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
FR2740339B1 (fr) 1995-10-26 1997-12-05 Oreal Utilisation d'au moins un inhibiteur de no-synthase dans le traitement des peaux sensibles
FR2740453B1 (fr) 1995-10-27 1998-01-16 Bieurope Melanges peptidiques, leur preparation et compositions cosmetiques les contenant
JP2681881B2 (ja) 1995-11-24 1997-11-26 ナショナル サイエンス カウンシル 抗ウイルス剤アシクロビルの経皮吸収製剤
US5789442A (en) 1996-01-18 1998-08-04 Schering Aktiengesellschaft Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
JPH09208460A (ja) 1996-01-31 1997-08-12 Lion Corp 貼付剤
JP4020989B2 (ja) 1996-03-06 2007-12-12 株式会社ノエビア 血流促進剤及びこれを配合して成る皮膚外用剤
GB9608408D0 (en) 1996-04-23 1996-06-26 Adams Michael A Treatment of erectile dysfunction
US5911980A (en) 1996-06-27 1999-06-15 Macrochem Corporation Lipophilic and amphiphilic or hydrophilic film-forming polymer compositions, and use thereof in topical agent delivery system and method of delivering agents to the skin
US5985317A (en) 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
US20020015713A1 (en) 1996-10-24 2002-02-07 Murdock Robert W. Methods and transdermal compositions for pain relief
US5891472A (en) 1996-11-19 1999-04-06 Meri Charmyne Russell Treatment of equine laminitis
JPH10167953A (ja) 1996-12-06 1998-06-23 Daicel Chem Ind Ltd 化粧品組成物
US5807957A (en) 1996-12-23 1998-09-15 Macrochem Corporation Cationic film-forming polymer compositions, and use thereof in topical agents delivery system and method of delivering agents to the skin
IL120531A (en) 1997-03-26 2006-12-31 Yissum Res Dev Co Nitric oxide donors and pharmaceutical compositions containing them
FR2762782B1 (fr) 1997-05-05 1999-06-11 Oreal Composition comprenant un milieu de culture de micro-organisme et utilisation
ATE499343T1 (de) 1997-07-03 2011-03-15 Us Gov Health & Human Serv Stickoxid freistetzende amidin- und enaminverwandte diazeniumdiolate, zubereitungen und verwendungen davon und verfahren zu ihrer herstellung
US5976566A (en) 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin
US6207713B1 (en) 1997-09-17 2001-03-27 Eric T. Fossel Topical and oral delivery of arginine to cause beneficial effects
US5922332A (en) * 1997-09-17 1999-07-13 Fossel; Eric T. Topical delivery of arginine to overcome pain
ES2340450T3 (es) * 1997-09-17 2010-06-02 STRATEGIC SCIENCE & TECHNOLOGIES, LLC Un suministro de arginina para el calentamiento de tejidos frios/enfriados.
US5895658A (en) 1997-09-17 1999-04-20 Fossel; Eric T. Topical delivery of L-arginine to cause tissue warming
US7629384B2 (en) 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US7914814B2 (en) 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
US6096759A (en) 1997-09-19 2000-08-01 Georgetown University Method for treating essential hypertension
US5906822A (en) 1997-09-25 1999-05-25 Macrochem Corporation Cationic film-forming polymer compositions, and use thereof in topical agents delivery system and method of delivering agents to the skin
US6037346A (en) 1997-10-28 2000-03-14 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6046244A (en) 1997-11-05 2000-04-04 Nexmed Holdings, Inc. Topical compositions for prostaglandin E1 delivery
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
CN1303279A (zh) 1998-06-01 2001-07-11 A·J·沃比斯卡 局部透皮疗法
US6103275A (en) 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide
US6117872A (en) 1998-06-23 2000-09-12 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of exercise performance by augmenting endogenous nitric oxide production or activity
JP2002519366A (ja) 1998-07-07 2002-07-02 トランスダーマル・テクノロジーズ・インコーポレーテツド 医薬的に活性な作用物質を迅速かつ非刺激的に経皮送達するための組成物、およびそのような組成物の調剤法およびそれらの送達
DE19830649C2 (de) 1998-07-09 2003-04-10 Lohmann Therapie Syst Lts Topisches Pflaster mit nichtsteroidalen Antirheumatika mit Säuregruppe
DE19831798A1 (de) 1998-07-15 2000-01-27 Mandorlo Investment Gmbh Luxem Mittel zur Pflege und/oder Behandlung von Haut und Gewebe
JP2002528400A (ja) 1998-10-26 2002-09-03 ユニバーシティー オブ マサチューセッツ アデノシンまたはアデノシン類似体を用いた皮膚の治療
US6261594B1 (en) 1998-11-25 2001-07-17 The University Of Akron Chitosan-based nitric oxide donor compositions
JP2000186028A (ja) 1998-12-21 2000-07-04 Nobuko Koga 化粧品
FR2787996B1 (fr) 1998-12-30 2002-05-10 Dior Christian Parfums Composition cosmetique ou dermatologique contenant un actif stimulant la synthese de la proteine hsp 32 dans la peau et methode de traitement cosmetique
AU3490300A (en) 1999-03-12 2000-10-04 Nitromed, Inc. Dopamine agonists in combination with nitric oxide donors, compositions and methods of use
MXPA01009140A (es) 1999-03-12 2003-07-14 Howard Cooper Troy Aparato formador de vapor para la aplicacion de materiales de recubrimiento a la superficie de la piel.
US6375672B1 (en) 1999-03-22 2002-04-23 Board Of Trustees Of Michigan State University Method for controlling the chemical and heat induced responses of collagenous materials
FR2794974B1 (fr) 1999-06-16 2001-08-17 Exsymol Sa Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique
CA2384080C (en) 1999-09-07 2012-03-20 Kabushiki Kaisha Soken Skin conditioner
US6565879B1 (en) 1999-12-16 2003-05-20 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers
US6562370B2 (en) 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers
US6558695B2 (en) 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
US6586000B2 (en) 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
US6582724B2 (en) 1999-12-16 2003-06-24 Dermatrends, Inc. Dual enhancer composition for topical and transdermal drug delivery
US6602912B2 (en) 2000-06-30 2003-08-05 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
US6719997B2 (en) 2000-06-30 2004-04-13 Dermatrends, Inc. Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
FR2802414B1 (fr) * 1999-12-20 2003-06-27 G Pharm Lab Composition, notamment cosmetique ou dermatologique, contenant des oligosaccharides, son procede de preparation et un procede de traitement cosmetique
KR100450804B1 (ko) * 2000-01-19 2004-10-01 미쓰비시덴키 가부시키가이샤 마이크로디바이스와 그 제조 방법
DE10003767A1 (de) * 2000-01-28 2001-10-04 Beiersdorf Ag Hautfreundliches Wirkstoffpflaster zur transdermalen Verabreichung nichtsteroidaler Antirheumatika
JP2001288068A (ja) 2000-04-06 2001-10-16 Nof Corp 皮膚化粧料
FR2810540B1 (fr) 2000-06-21 2004-04-30 C3D Nouvelles preparations cosmetiques ou hygieniques sous forme de dispersion
JP2002003373A (ja) 2000-06-27 2002-01-09 Shiseido Co Ltd 皮膚外用剤
US6538033B2 (en) 2000-08-29 2003-03-25 Huntington Medical Research Institutes Nitric oxide donor compounds
JP2004520388A (ja) 2001-01-25 2004-07-08 ザ ジェネラル ホスピタル コーポレーション しわを治療するためのnos阻害剤
WO2002087700A1 (en) 2001-04-26 2002-11-07 The Procter & Gamble Company Method, kit and device for the treatment of cosmetic skin conditions
DE10128910A1 (de) 2001-06-15 2002-12-19 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus Arginin und Ascorbinsäure zur Hautstraffung
US20060153931A1 (en) 2001-12-06 2006-07-13 Stamler Jonathan S Prevention of flap necrosis in plastic surgery
US20030157185A1 (en) 2002-02-08 2003-08-21 Lou Paradise Topical treatment of neuropathy
US20050226821A1 (en) 2002-02-22 2005-10-13 Jacob Waugh Cosmetic formulations containing l-arginine oligomers
US20030219494A1 (en) 2002-03-20 2003-11-27 Smith Maree Therese Compositions and methods of using them
WO2003080104A2 (en) 2002-03-22 2003-10-02 Applied Research Systems Ars Holding N.V. Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
JP2003286129A (ja) 2002-03-27 2003-10-07 Hakugen:Kk 痩身シート材
WO2003086282A2 (en) 2002-04-05 2003-10-23 Nitromed, Inc. Nitric oxide donors, compositions and methods of use
RU2229286C2 (ru) 2002-05-27 2004-05-27 Пятигорская государственная фармацевтическая академия Мазь ибупрофена, приготовленная на полиэтиленоксидной основе, обладающая противовоспалительным действием
JP4419368B2 (ja) 2002-07-25 2010-02-24 小野薬品工業株式会社 プロスタグランジン誘導体およびその誘導体を有効成分として含有する薬剤
US20020168424A1 (en) 2002-07-31 2002-11-14 Dr. Mohsen Shahinpoor Nitric oxide (NO) donor+cGMP-PDE5 inhibitor as a topical drug for glaucoma
US7241456B2 (en) 2002-10-25 2007-07-10 Australian Importers Ltd. Formulations for topical delivery of bioactive substances and methods for their use
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
CA2525465A1 (en) 2003-05-16 2004-11-25 Lotus Pharmaceutical Co., Ltd. Topical composition for transdermal administration
AU2003903037A0 (en) 2003-06-17 2003-07-03 Institute Of Nutraceutical Research Connective tissue derived polypeptides
WO2004112723A2 (en) 2003-06-20 2004-12-29 Ronald Aung-Din Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
US20050069590A1 (en) 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
JP2005200370A (ja) 2004-01-16 2005-07-28 Nikko Chemical Co Ltd 一酸化窒素産生促進剤およびその利用
WO2005081964A2 (en) 2004-02-23 2005-09-09 Strategic Science & Technologies, Llc Topical delivery of a nitric oxide donor to improve body and skin appearance
US20050196418A1 (en) 2004-03-04 2005-09-08 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
US9205062B2 (en) 2004-03-09 2015-12-08 Mylan Pharmaceuticals, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
CA2563670C (en) 2004-04-19 2014-09-16 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
US20110028548A1 (en) 2004-04-19 2011-02-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US20090105336A1 (en) 2004-04-19 2009-04-23 Strategic Science & Technologies, Llc Beneficial Effects of Increasing Local Blood Flow
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
ITMI20041492A1 (it) 2004-07-23 2004-10-23 Italiano Biochimico Far Maceut Nuovo dispositivo per il rilascio di principi attivi
US20070087977A1 (en) 2004-11-16 2007-04-19 Wendye Robbins Methods and compositions for treating pain
ES2437201T3 (es) 2005-03-03 2014-01-09 Green, Monique Renata Composiciones de geles tópicos
US7442690B2 (en) 2005-03-14 2008-10-28 P & L Enterprise Llc Topical treatment for psoriasis
EP1770086A1 (de) 2005-09-29 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co. KG Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
JP5111117B2 (ja) 2005-12-22 2012-12-26 興和株式会社 ステロイドの経時的安定性が改善された外用製剤
WO2008017855A1 (en) 2006-08-11 2008-02-14 The University Of Warwick Osmium compounds
EP2117506A2 (en) 2006-12-13 2009-11-18 Stephen M. Tuel Methods of making pharmaceutical components for customized drug products
MX337408B (es) 2007-03-22 2016-03-03 Berg Llc Formulaciones topicas que tienen biodisponibilidad aumentada.
US8686040B2 (en) 2008-03-31 2014-04-01 Rdd Pharma Ltd. Method for treating anal pruritis and other perianal disorders
US8842076B2 (en) * 2008-07-07 2014-09-23 Rockstar Consortium Us Lp Multi-touch touchscreen incorporating pen tracking
US8969081B2 (en) 2008-12-10 2015-03-03 The Trustees Of Columbia University In The City Of New York Caudal motor neuron derived from embryonic stem cells under conditions essentially free of any retinoid
EP3282021A1 (en) 2009-03-09 2018-02-14 Bioatla, LLC Mirac proteins
EP2445492B1 (en) 2009-06-24 2016-09-28 Strategic Science & Technologies, LLC Topical composition containing ibuprofen
EP2445493A1 (en) 2009-06-24 2012-05-02 Strategic Science & Technologies, LLC Topical composition containing naproxen
CN114668851B (zh) 2010-12-29 2024-11-01 战略科学与技术有限责任公司 勃起功能障碍和其它适应症的治疗
JP2014501284A (ja) 2010-12-29 2014-01-20 ストラテジック サイエンス アンド テクノロジーズ, エルエルシー Cox−2阻害剤および関連化合物、ならびにそれらを送達するためのシステムおよび方法
WO2012092523A1 (en) 2010-12-29 2012-07-05 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
CN103429246A (zh) 2010-12-29 2013-12-04 战略科学与技术有限责任公司 真菌感染和其它适应症的治疗的透皮递送
JP2014501285A (ja) 2010-12-29 2014-01-20 ストラテジック サイエンス アンド テクノロジーズ, エルエルシー 片頭痛および他の適応症の処置のための方法およびシステム
EP2676142A4 (en) 2011-02-18 2015-06-03 Prec Biolog Inc METHODS AND COMPOSITIONS RELATED TO BLOOD CREATION TESTS
JP5727258B2 (ja) * 2011-02-25 2015-06-03 ウイングアーク1st株式会社 分散型データベースシステム

Similar Documents

Publication Publication Date Title
JP2012062328A5 (enExample)
Pham et al. Strategies for the design of orally bioavailable antileishmanial treatments
JP2011140525A5 (enExample)
JP2014501284A5 (enExample)
JP2014504592A5 (enExample)
JP2012515184A5 (enExample)
JP2013035860A5 (enExample)
JP2007532696A5 (enExample)
JP2007532697A5 (enExample)
JP2009280627A5 (enExample)
JP2015518485A5 (enExample)
RU2016105581A (ru) Способ лечения острого, хронического и подострого кашля и непреодолимого желания откашляться
JP2016135812A5 (enExample)
JP2014510728A5 (enExample)
JP2014501286A5 (enExample)
JP2013534248A5 (enExample)
JP2014501285A5 (enExample)
JP2013516482A5 (enExample)
JP2014513722A5 (enExample)
BR112015009503A2 (pt) dispostivo de tratamento extracorporal do sangue
JP2016539921A5 (enExample)
JP2013541583A5 (enExample)
MX2013012206A (es) Metodo para producir substancias con gas sobresaturado,dispositivo de suministro transdermico de las mismas, y usos de las mismas.
JP2016515623A5 (enExample)
WO2012051614A3 (en) Delivery of hydrophobic bioactive agents